Il­lu­mi­na names Ho­log­ic CEO as new board mem­ber and chair

Il­lu­mi­na’s board ap­point­ed two new mem­bers, in­clud­ing Ho­log­ic CEO Stephen MacMil­lan as the non-ex­ec­u­tive chair, a move that fol­lowed a proxy fight that saw share­hold­ers oust the com­pa­ny’s board chair.

The DNA se­quenc­ing com­pa­ny al­so ap­point­ed Scott Ullem, the CFO of Ed­wards Life­sciences, to the board, ac­cord­ing to a com­pa­ny state­ment.

Il­lu­mi­na’s plans to add two new board mem­bers came as Carl Ic­ahn waged a board proxy cam­paign cul­mi­nat­ing with share­hold­ers elect­ing his can­di­date, An­drew Teno, over board chair John Thomp­son. Il­lu­mi­na CEO Fran­cis deS­ouza sur­vived a threat to his board seat by se­cur­ing more than twice the share­hold­er votes than his chal­lenger. An­oth­er Il­lu­mi­na can­di­date, Robert Ep­stein, was al­so elect­ed and re­mained on the board.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER